Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study. | PLoS One | 2015 | 25798582 | PubTator, text mining | PubMed |
| MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors. | Theranostics | 2015 | 25767615 | PubTator, text mining | PubMed |
| Pharmacogenetic profile of a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal. | Public Health Genomics | 2015 | 25766488 | PubTator, text mining | PubMed |
| Coffee consumption and bladder cancer: a meta-analysis of observational studies. | Sci Rep | 2015 | 25761588 | PubTator, text mining | PubMed |
| Risk factors associated with adverse reactions to antituberculosis drugs. | J Bras Pneumol | 2015 | 25750677 | PubTator, text mining | PubMed |
| Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. | Clin Infect Dis | 2015 | 25722197 | PubTator, text mining | PubMed |
| The role of genotypes that modify the toxicity of chemical mutagens in the risk for myeloproliferative neoplasms. | Int J Environ Res Public Health | 2015 | 25719551 | PubTator, text mining | PubMed |
| Incidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study. | Medicine (Baltimore) | 2015 | 25715268 | PubTator, text mining | PubMed |
| Noncanonical secondary structure stabilizes mitochondrial tRNA(Ser(UCN)) by reducing the entropic cost of tertiary folding. | J Am Chem Soc | 2015 | 25705930 | PubTator, text mining | PubMed |
| Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity. | Arch Toxicol | 2015 | 25693865 | PubTator, text mining | PubMed |
| Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate. | Pharmacol Res Perspect | 2015 | 25692017 | PubTator, text mining | PubMed |
| Five-aminosalicylic Acid: an update for the reappraisal of an old drug. | Gastroenterol Res Pract | 2015 | 25685145 | PubTator, text mining | PubMed |
| Enabling the curation of your pharmacogenetic study. | Clin Pharmacol Ther | 2015 | 25670512 | PubTator, text mining | PubMed |
| Husband's smoking status and breast cancer risk in Japan: From the Takayama study. | Cancer Sci | 2015 | 25645582 | PubTator, text mining | PubMed |
| Systematic identification of molecular links between core and candidate genes in breast cancer. | J Mol Biol | 2015 | 25640309 | PubTator, text mining | PubMed |
| Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines. | Cancer Med | 2015 | 25627111 | PubTator, text mining | PubMed |
| Dietary heterocyclic amine intake, NAT2 genetic polymorphism, and colorectal adenoma risk: the colorectal adenoma study in Tokyo. | Cancer Epidemiol Biomarkers Prev | 2015 | 25604583 | PubTator, text mining | PubMed |
| Correlation between NAT2 gene polymorphism and cirrhotic portal hypertension in the Chinese population. | Genet Test Mol Biomarkers | 2015 | 25574899 | PubTator, text mining | PubMed |
| Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung. | Exp Ther Med | 2015 | 25574196 | PubTator, text mining | PubMed |
| Protein interactome of muscle invasive bladder cancer. | PLoS One | 2015 | 25569276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=81